Joint Formulary & PAD

Eflornithine monohydrate chloride - Hirsutism

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Cream
Associated Icons :
NFD1
SPC
Restrictions / Comments :

Documentation

PAD Profile

ChemicalSubstance :
Eflornithine monohydrate chloride
Indication :
Hirsutism
Group Name :
Keywords :
Brand Names Include :
Vaniqa
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Committee Recommendations (1)

The APC recommend that Vaniqua cream should not be routinely prescribed and it should be added to the Low Priority Procedures List.

Other Indications

Below are listed other indications that Eflornithine monohydrate chloride is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Hirsutism.

  • No records returned.